| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 17 |
| 1 | CLOZAPINE | 14 |
| 2 | METHOTREXATE | 14 |
| 3 | METHOTREXATE SODIUM | 14 |
| 4 | RIBAVIRIN | 13 |
| 5 | PREDNISONE | 12 |
| 6 | PEGINTERFERON ALFA-2A | 11 |
| 7 | PREDNISOLONE | 10 |
| 8 | PREDNISOLONE ORAL | 10 |
| 9 | PREDNISOLONE ORAL SOLUTION | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIFUNGAL LIQUID SPRAY | 1 | 0.0053 |
| 1 | GABA (GAMMA-AMINOBUTYRIC ACID) | 1 | 0.0047 |
| 2 | TOLNAFTATE 1% | 1 | 0.0034 |
| 3 | DIFLUPREDNATE OPHTHALMIC | 3 | 0.0034 |
| 4 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 2 | 0.0026 |
| 5 | RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE | 2 | 0.0013 |
| 6 | NITISINONE | 1 | 0.0010 |
| 7 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 8 | CYCLOSERINE | 2 | 0.0009 |
| 9 | SODIUM CITRATE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 29 |
| 1 | Complement Inhibitor [EPC] | 18 |
| 2 | Kinase Inhibitor [EPC] | 18 |
| 3 | Atypical Antipsychotic [EPC] | 17 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 15 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 6 | Nucleoside Analog Antiviral [EPC] | 14 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 8 | Platinum-based Drug [EPC] | 12 |
| 9 | Benzodiazepine [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | Complement Inhibitor [EPC] | 18 | 0.0003 |
| 5 | Radioligand Therapeutic Agent [EPC] | 4 | 0.0003 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 8 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |